The MaxCyte STX® Scalable Transfection System uses Flow Electroporation™ Technology for rapid, high-performance engineering of cells for a broad array of applications. It addresses the R&D arena from early-stage development through pre-clinical work, including toxicology studies. Use the MaxCyte STX to improve the quality and time-to-market of your vaccines, small molecule drugs and biotherapeutics candidates.
One Platform... Endless ApplicationsRead More
The MaxCyte STX has enabled us to meet our yearly protein production goal in five months!